Eric Kmiec

Seminars

Thursday 30th October 2025
Discussing Shifts in the Gene Editing Landscape to Transition from Ex Vivo to In Vivo Gene Editing
3:30 pm
  • Review the benefits of in vivo genome editing approaches from a patient perspective
  • Explore the need to refocus the safety guidelines for in vivo treatments compared to ex vivo treatments
  • Evaluate what approaches and strategies can be harnessed from ex vivo therapies to enhance in vivo therapy development